Chemomab Therapeutics Ltd. Prepaid Expense, Current
Chemomab Therapeutics Ltd. (CMMB) had Prepaid Expense, Current of $2.86 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2026-03-23
- 2025-12-31: Prepaid Expense, Current $2.86M.
- 2024-12-31: Prepaid Expense, Current $1.44M.
- 2023-12-31: Prepaid Expense, Current $748.00K.
- 2022-12-31: Prepaid Expense, Current $1.31M.
| Period end | Prepaid Expense, Current |
|---|---|
| 2025-12-31 | $2.86M 20-F · filed 2026-03-23 |
| 2024-12-31 | $1.44M 20-F · filed 2026-03-23 |
| 2023-12-31 | $748.00K 20-F · filed 2025-04-04 |
| 2022-12-31 | $1.31M 20-F · filed 2024-03-28 |
| 2021-12-31 | $1.35M 10-K · filed 2023-03-20 |
| 2020-12-31 | $67.00K 10-K · filed 2022-03-30 |